In December 2020, FLCCC President and Chief Medical Officer, Dr. Pierre Kory, a pulmonary and critical care specialist, testified to the benefits of ivermectin before a number of COVID-19 panels, including the Senate Committee on Homeland Security and Governmental Affairs.27 In riveting testimony, Kory described: Six studies with a total of over 2,400 patients—all showing near-perfect prevention of transmission of this virus in people exposed to COVID-19 . . . Three RCT’s randomized controlled studies and multiple large case series—involving over 3,000 patients showing stunning recovery among
...more
